Vaccine maker Novavax, despite concerns for its future, to maintain partnership with Ottawa
In an effort to get COVID-19 vaccines made in Canada, the federal government announced in February 2021 a deal between the National Research Council’s Biologics Manufacturing Centre facility and Novavax to begin producing its vaccine in Montreal.
“At this time, there are no expected changes to the partnership between Novavax and the BMC,” said Laurie Bouchard, a spokesperson for Industry Minister Francois-Philippe Champagne, in an email to Global News.Jim Kelly, Novavax’s chief financial officer, told investors on that call the company lost more than $600 million last year, and doesn’t expect to sell any new vaccine during the first three months of 2023. It also fears funding from the United States government could be cut.
When the government announced its partnership with Novavax in 2021, Champagne said the Montreal facility — which has the potential to produce around two million doses of vaccine a month — would be in a position to begin production at the end of 2021. However, the NRC said on its website in December that it is still working on the “technology transfer” required to produce the vaccine.
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Novavax shares plunge after COVID-19 vaccine maker raises doubts over its future - National | Globalnews.caNovavax — whose COVID-19 vaccine is its only marketed product after 35 years in business — on Tuesday flagged significant uncertainty around its 2023 revenue.
اقرأ أكثر »
Novavax shares slump after COVID-19 vaccine maker raises doubts about futureNovavax on Tuesday flagged significant uncertainty around its 2023 revenue, funding from the U.S. government and pending arbitration with global vaccine alliance Gavi
اقرأ أكثر »
B.C.’s free contraception plan renews push for Ottawa, other provinces to follow suit | Globalnews.caObstetricians and reproductive rights advocates say other countries, including the United Kingdom, already provide free contraception as part of their health-care plans.
اقرأ أكثر »
Novavax tumbles after warning of 'substantial doubt' over future - BNN BloombergNovavax Inc. said there's substantial doubt about its ability to stay in business through next year, the latest warning from the company after it struggled to develop and sell a COVID-19 vaccine.
اقرأ أكثر »
U.S. company that made deal to produce COVID vaccine in Canada warns it could go out of businessNovavax executives told investors that there is uncertainty surrounding the company\u0027s ability to fund operations as the COVID\u002D19 vaccine market changes
اقرأ أكثر »